Veterinary Medicines

Linco-Sol 400 mg/g powder for use in drinking water for pigs and chickens

Authorised
  • Lincomycin
Download as PDF

Product identification

Medicine name:
Linco-Sol 400 mg/g powder for use in drinking water for pigs and chickens
LincoScan 400 mg/g Proszek do podawania w wodzie do picia
Active substance:
  • Lincomycin
Target species:
  • Pig
  • Chicken (broiler)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Lincomycin
    400.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for use in drinking water
Withdrawal period by route of administration:
  • Oral use
    • Pig
      • Meat and offal
        1
        day
    • Chicken (broiler)
      • Meat and offal
        5
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FF02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Lavet Kft.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lavet Kft.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 2063
Date of authorisation status change:
Reference member state:
  • Hungary
Procedure number:
  • HU/V/0111/001
Concerned member states:
  • Czechia
  • Germany
  • Greece
  • Italy
  • Lithuania
  • Poland
  • Portugal
  • Romania
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 26/08/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."